<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335277">
  <stage>Registered</stage>
  <submitdate>18/03/2010</submitdate>
  <approvaldate>23/03/2010</approvaldate>
  <actrnumber>ACTRN12610000239066</actrnumber>
  <trial_identification>
    <studytitle>Ultrasound guided corticosteroid injection for plantar fasciitis: a randomised controlled trial</studytitle>
    <scientifictitle>Ultrasound guided corticosteroid injection for treatment of pain associated with plantar fasciitis: a randomised controlled trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Plantar fasciitis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Ultrasound guided injection of the plantar fascia with 1mL of 4mg/mL dexamethasone sodium phosphate</interventions>
    <comparator>Ultrasound guided injection of the plantar fascia with 1mL normal (isotonic) saline</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain measured on a visual analogue scale</outcome>
      <timepoint>Baseline, then 1, 2 and 3 months post randomisation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Plantar fascia thickness measured by diagnostic ultrasound</outcome>
      <timepoint>Baseline, then 1, 2 and 3 months post randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Function measured by the Foot Health Status Questionnaire</outcome>
      <timepoint>Baseline, then 1, 2 and 3 months post randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Daily use of oral analgesic medication, self-reported in a diary</outcome>
      <timepoint>Baseline, then 1, 2 and 3 months post randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>First step pain measured on a visual analogue scale</outcome>
      <timepoint>Baseline, then 1, 2 and 3 months post randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>History of pain beneath the heel for minimum 8 weeks

Minimum heel pain magnitude of 20mm on visual analogue scale

Sensitivity to palpation of medial calcaneal tubercle and/or the proximal plantar fascia

Minimum plantar fascia thickness value of 4.0mm as measured by ultrasound</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Corticosteroid injection for plantar fasciitis within previous 6 months. Known hypersensitivity to lignocaine or dexamethasone. Current skin or soft tissue infection near injection site. Current pregnancy. Systemic inflammatory disease. Diabetes Mellitus. Previous local surgery or trauma. Commencement of any treatment for plantar fasciitis within four weeks prior to enrolment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation will be concealed in a password-protected computer file.</concealment>
    <sequence>Treatment allocation will be performed according to a computer-generated random allocation sequence.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>17/05/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Department of Podiatry, La Trobe University</primarysponsorname>
    <primarysponsoraddress>Bundoora, Victoria, 3086</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Australasian Podiatry Council</fundingname>
      <fundingaddress>89 Nicholson Street
Brunswick East
Victoria, 3057</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Musculoskeletal Research Centre, La Trobe University</sponsorname>
      <sponsoraddress>Bundoora, Victoria, 3086</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this project is to evaluate the effectiveness of corticosteroid injection versus normal saline (placebo) for treatment of chronic pain beneath the heel (plantar fasciitis).</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>La Trobe University Human Ethics Committee</ethicname>
      <ethicaddress>Bundoora, Victoria, 3086</ethicaddress>
      <ethicapprovaldate>16/02/2010</ethicapprovaldate>
      <hrec>09062</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrew McMillan</name>
      <address>Department of Podiatry
La Trobe University
Bundoora, Victoria, 3086</address>
      <phone>+61 3 9479 5785</phone>
      <fax />
      <email>a.mcmillan@latrobe.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Andrew McMillan</name>
      <address>Department of Podiatry
La Trobe University
Bundoora, Victoria, 3086</address>
      <phone>+61 3 9479 5785</phone>
      <fax />
      <email>a.mcmillan@latrobe.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Andrew McMillan</name>
      <address>Department of Podiatry
La Trobe University
Bundoora, Victoria, 3086</address>
      <phone>+61 3 9479 5785</phone>
      <fax />
      <email>a.mcmillan@latrobe.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>